Critical Assessment of Risk Factors for Complications After Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy for Pseudomyxoma Peritonei

被引：0
|
作者：
Akshat Saxena
Tristan D. Yan
Terence C. Chua
David L. Morris
机构：
[1] University of New South Wales,Department of Surgery, St. George Hospital
来源：
Annals of Surgical Oncology | 2010年 / 17卷
关键词：
Cytoreductive Surgery; Severe Morbidity; Peritoneal Cancer Index; Pseudomyxoma Peritonei; Peritonectomy Procedure;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1291 / 1301
页数：10
相关论文
共 50 条
  • [31] FEASIBILITY OF RADICAL CYTOREDUCTIVE SURGERY AND HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY FOR PSEUDOMYXOMA PERITONEI OF APPENDICEAL ORIGIN
    Jarvinen, P.
    Ristimaki, A.
    Kantonen, J.
    Lepisto, A.
    SCANDINAVIAN JOURNAL OF SURGERY, 2013, 102 (03) : 145 - 151
  • [32] Is a Prognostic Nomogram for Complete Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Pseudomyxoma Peritonei Useful?
    Levine, Edward A.
    JAMA SURGERY, 2023, 158 (05) : 531 - 531
  • [33] Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy for Pseudomyxoma Peritonei Arising from Urachus
    Yang Liu
    Haruaki Ishibashi
    Masamitsu Hirano
    Kazuyoshi Takeshita
    Akiyoshi Mizumoto
    Masumi Ichinose
    Eisei Nishino
    Ippei Kashu
    Yoshihiro Yamamoto
    Paul H. Sugarbaker
    Yutaka Yonemura
    Annals of Surgical Oncology, 2015, 22 : 2799 - 2805
  • [34] Upfront Compared to Delayed Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy for Pseudomyxoma Peritonei Is Associated With Considerably Lower Perioperative Morbidity and Recurrence Rate
    Chua, Terence C.
    Liauw, Winston
    Zhao, Jing
    Morris, David L.
    ANNALS OF SURGERY, 2011, 253 (04) : 769 - 773
  • [35] Cytoreductive Surgery and Hyperthermic Chemotherapy for Intrathoracic Pseudomyxoma Peritonei
    Kawaguchi, Yo
    Hanaoka, Jun
    ANNALS OF THORACIC SURGERY, 2020, 110 (06): : E541 - E543
  • [36] Relapse of Pseudomyxoma Peritonei After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Pattern of Failure, Clinical Management and Outcomes
    Baratti, Dario
    Kusamura, Shigeki
    Guaglio, Marcello
    Milione, Massimo
    Pietrantonio, Filippo
    Cavalleri, Tommaso
    Morano, Federica
    Deraco, Marcello
    ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (01) : 404 - 414
  • [37] Quality of life after cytoreductive surgery plus early intraperitoneal postoperative chemotherapy for pseudomyxoma peritonei: A prospective study
    Jess, Per
    Iversen, Lene H.
    Nielsen, Mette B.
    Hansen, Flemming
    Laurberg, Soren
    Rasmussen, Peter C.
    DISEASES OF THE COLON & RECTUM, 2008, 51 (06) : 868 - 874
  • [38] Relapse of Pseudomyxoma Peritonei After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Pattern of Failure, Clinical Management and Outcomes
    Dario Baratti
    Shigeki Kusamura
    Marcello Guaglio
    Massimo Milione
    Filippo Pietrantonio
    Tommaso Cavalleri
    Federica Morano
    Marcello Deraco
    Annals of Surgical Oncology, 2023, 30 : 404 - 414
  • [39] Survival prediction by Bayesian network modeling for pseudomyxoma peritonei after cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy
    Zhao, Xin
    Li, Xinbao
    Lin, Yulin
    Ma, Ru
    Zhang, Ying
    Xu, Dazhao
    Li, Yan
    CANCER MEDICINE, 2023, 12 (03): : 2637 - 2645
  • [40] Early recurrence of pseudomyxoma peritonei following treatment failure of cytoreductive surgery and perioperative intraperitoneal chemotherapy is indicative of a poor survival outcome
    Terence C. Chua
    Winston Liauw
    David L. Morris
    International Journal of Colorectal Disease, 2012, 27 : 381 - 389
12345